FDA rules on wireless devices; Neovasc's revenue leaps 71%;

@FierceMedDev: Special Report: How did Israel become a hotbed for medical devices? Feature | Follow @FierceMedDev

@DamianFierce: FDA's former IT boss Eric Perakslis nails down industry gig. Story from FierceBiotechIT.com | Follow @DamianFierce

@MarkHFierce: Second Sight achieved the holy grail for new devices: CMS reimbursement. Press release | Follow @MarkHFierce

@MichaelGFierce: St. Jude nets FDA approval for low-radiation ablation catheters. News | Follow @MichaelGFierce

> The FDA has finalized its guidance on the use of wireless technology in medical devices. Article

> Natus ($BABY) won FDA and Health Canada clearances for its new electrodiagnostic system. Item

> Devicemaker Neovasc ($NVC) increased its revenue 71% to $2.8 million last quarter, narrowing its net loss 20% to $1.2 million. Results

> Immunetics won FDA approval for its BacTx test, which can detect aerobic, anaerobic, gram-negative and gram-positive bacteria in a single assay. News

> Diagnostics outfit Trovagene ($TROV) posted a $5.3 million net loss last quarter, 55% below the same period last year, but the company is accelerating toward the launch of microRNA tests it believes will boost revenue. Item

> The University of Rochester has launched a program that pairs its biomedical engineering students with clinicians, focusing on the development of new medical devices. Story

Biotech News

@FierceBiotech: ICYMI yesterday: The hottest disease field for biotech startups and M&A might surprise you (not cancer). Article | Follow @FierceBiotech

@JohnCFierce: Two biotechs--Alexion and Regeneron--in top 5 of Forbes' top 100 innovators. Impressive. Article | Follow @JohnCFierce

@RyanMFierce: ICYMI: The man who cured aging? Industry Voices | Follow @RyanMFierce

@EmilyMFierce: Seattle BioMed wins $16M NIH grant for tuberculosis research. Article | Follow @EmilyMFierce

> Forest, Almirall combo COPD drug stumbles as Big Pharma rivals race ahead. Story

> M&A watch: Amgen and Onyx haggle over Kyprolis data in stalled buyout talks. Report

> Biotech dealmaking pace slows, but PhII remains popular. Article

Pharma News

@FiercePharma: New data cuts link between preventive use of Propecia/Proscar and faster-growing prostate tumors. More | Follow @FiercePharma

@CarlyHFierce: South Africa's Adcock Ingram so far staying true to suitor CFR - still in exclusive talks after $1.3B bid. Report | Follow @CarlyHFierce

> NY fund trustee to continue push for exec-pay clawbacks at Abbott. Story

> Which are pharma's top 4 innovators? Hint: It's not the big guys. Report

> Novartis opens internal China probe after former rep demanded $800K. News

Pharma Manufacturing News

@EricPFierce: Not all of the Merck plants in Ireland have seen jobs cut. A plant in Swords added 70 people last year. Report | Follow @EricPFierce

> Deaths tied to recalled drugs from Texas compounder. More

> Jubilant HollisterStier adds to global sterile manufacturing supply. Report

> FDA takes deep dive into opioid APIs. More

> Sanofi U.K. plant benefits from SkyePharma progress. Article

> Deaths tied to recalled drugs from Texas compounder. Story

Vaccines News

> Vaccine calms fears of meningitis becoming AIDS-like epidemic. More

> Researchers aim at trial to test whether BCG vaccine cuts risk of allergies. Report

> Study reconfirms safety of flu vaccine in pregnant women. Story

> Researchers aim at trial to test whether BCG vaccine cuts risk of allergies. More

> Incredulity turns to praise as malaria vaccine posts positive PhI data. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.